Cancer Treatment Outcomes: Survival and cGVHD Incidence, Lab Reports of Pharmaceutical Statistics

A series of supplementary figures related to treatment outcomes in a clinical study, likely focused on cancer. The figures depict overall survival, relapse-free survival, and the cumulative incidence of chronic graft-versus-host disease (cgvhd) and death, both with and without cgvhd. Specific figures highlight the incidence of grade 3 cgvhd and death without grade 3 cgvhd. These figures are essential for understanding the efficacy and safety profiles of different treatment regimens. The data provides insights into the long-term effects of treatments, including survival rates and the development of complications such as cgvhd. The figures are crucial for clinicians and researchers in evaluating treatment strategies and improving patient outcomes. A valuable resource for those studying oncology and hematology.

Typology: Lab Reports

2022/2023

Uploaded on 05/14/2025

victor-tennyson-baidoo
victor-tennyson-baidoo 🇺🇸

1 document

1 / 6

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
1. Supplementary Figures
1.1. Figure 1. Overall Survival by Treatment Group
pf3
pf4
pf5

Partial preview of the text

Download Cancer Treatment Outcomes: Survival and cGVHD Incidence and more Lab Reports Pharmaceutical Statistics in PDF only on Docsity!

1. Supplementary Figures

1.1. Figure 1. Overall Survival by Treatment Group

1.2. Figure 2. Relapse-Free Survival by Treatment Group

1.4. Figure 4. Cumulative Incidence of Death Without cGVHD

1.5. Figure 5. Cumulative Incidence of G3 cGVHD